MCB vs EUS-FNA for Preoperative Pathological Evaluation of Gastric SMT
Recruiting
N/A
Interventional Study
Gastrointestinal Stromal Tumor of Stomach
Submucosal Tumor of Stomach
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Diagnostic
- Participants needed
- 96 (estimated)
- Sponsor
- Peking University People's Hospital · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Gastrointestinal stromal tumors (GISTs) are the most common submucosal tumors (SMTs) of the stomach. The 2022 European Society of Oncology ESMO Diagnosis and Treatment Guidelines recommend that GISTs undergo biopsy with a clear pathological diagnosis and should be removed unless there are significant complications. But currently, the diagnostic rate of EUS-FNA for upper gastrointestinal subcutaneo…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Endoscopic evaluation considers gastric submucosal tumors (SMTs) with a diameter of ≥ 15mm
Exclusion Criteria:
* Endoscopic non bulging lesions.
* The upper gastrointestinal lesions measured by Endoscopic Ultrasonography(EUS) are less than 15 mm.
* Lesions that do not requir…
Contacts